Oncolytic Virotherapy Market: Is 2026 the Year "Living Drugs" Finally Crack the Code of Solid Tumors?
As of January 23, 2026, the oncolytic virotherapy market is identifying as the most high-potential frontier in immuno-oncology, with its 2026 valuation reaching approximately $30 million for specialized platforms, while the broader oncolytic virus therapy sector is projected to hit $1.15 billion by 2030. The 2026 landscape is defined by an explosive CAGR of 23.6% to 26.9%, fueled by the success...
0 Comentários 0 Compartilhamentos 268 Visualizações 0 Anterior